Ulixacaltamide

Name: Ulixacaltamide in Essential tremor: Definition and etiology
Published: 2026-09-14T15:39:06-04:00

Essential tremor

Manufacturer: Praxis Precision Medicines
Regulatory submission: NDA submitted by February 2026
Launch: Not announced
Last updated: September 19, 2026

Section

Product information and disease description Place of product in therapy Disease description

Definition and etiology

1 evidence topic · 1 source

Sporadic disease and familial susceptibility

“ET is often sporadic” (opens the source at this quote in a new tab)
“first-degree relatives of patients with ET are 5 times more likely to develop ET compared to the general population” (opens the source at this quote in a new tab)